See also this year's filing and all EDGAR filings for this company.
PDF Report 0001553643_2025_Relmada_Therapeutics_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001553643, Relmada Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 45,795,843 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 21,975 |
| 4 | LiabilitiesCurrent | 10,291,390 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 4,467 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 36,680,660 |
| 9 | ResearchAndDevelopmentExpense | 40,808,381 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 4,249,188 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 45,817,818 |
| 1 | Liabilities | 10,295,857 |
| 2 | Expenses | 77,489,041 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 35,521,961 |
| 5 | NetIncome | -73,239,853 |
| 6 | ComprehensiveNetIncome | -73,239,853 |
| 7 | BaseVar | 68,925,952 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.150 |
| 9 | EconomicCapitalRatio | 1.56 |
Edgar->Model Mapping
Feature Distribution
Change over Time
